Stem cells in the treatment of Gilbert’s syndrome
Gilbert’s syndrome, characterized by unconjugated hyperbilirubinemia, may benefit from stem cell therapy. Cellule staminali ematopoietiche, known for their ability to differentiate into various blood cells, offer a promising approach. By targeting the underlying defects in bilirubin metabolism, stem cell transplantation holds potential for improving liver function and reducing bilirubin levels, thus alleviating the symptoms associated with Gilbert’s syndrome.